OncoZenge extends payment deadline for remaining SEK 10.1 million private placement proceeds
Reuters2026/08/14 14:20- OncoZenge extended the payment deadline to Aug. 28 for SEK 10.1 million of remaining proceeds in a directed share issue.
- Payment was originally due Aug. 14 in the private placement to Sichuan Yangtian Bio-Pharmaceutical.
- The investor cited an expired SAFE currency-exchange certificate as the reason for the delay.
- A further partial payment of SEK 5 million is expected in August.
- Market update planned once proceeds are received and the share issue is registered, in part or in full.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley raises Honeywell target price to $250
Bitcoin Makes History With First-Ever Green August During a Bear Market
AI "hunger" fuels IPO boom! SB Energy (SBE.US), backed by SoftBank and OpenAI, applies for US listing.
SB Energy Corp. (SBE.US), a power infrastructure company jointly supported by SoftBank Group Corp. and OpenAI, has officially submitted an application for an initial public offering (IPO) to the U.S. Securities and Exchange Commission (SEC).
Bell Copper says Perseverance copper project drilling of hole K-24 continues in Arizona
Crypto prices
More
